DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Theodore C, James ND, Turesson I, Rosenthal MA, Eisenberger MA.
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.
N Engl J Med 2004;
351: 1502-1512
We do not assume any responsibility for the contents of the web pages of other providers.